Received Jul 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y015108 | — |
no symptoms reported; received improperly stored VARIVAX; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 19-Jun-2025, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) injection 0.5 mL (lot# Y015108, expiration date: 06-Sep-2026; strength, route of administration and anatomical site were not reported) administered by a health professional for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (dose, route of administration, lot # and expiration date were not reported). It was reported that the vaccine was administered after being improperly stored at 6.3 F for 16 minutes (Product storage error). No symptoms were reported (No adverse event). This is one of several reports received from the same reporter. Follow up information has been received from the nurse on 11-Jul-2025. This report referred to a 5-year-old male patient. On 19-Jun-2025, the patient also received Diphtheria vaccine toxoid;Pertussis vaccine acellular 3-component;Polio vaccine inact 3v (Vero);Tetanus vaccine toxoid (Kinrix). There had been no patient events occurring since the vaccination.
KINRIX; Sterile diluent